Kendall SCD™ 700 Controller SMART COMPRESSION™
$4,576.00
The Kendall SCD™ 700 Controller SMART COMPRESSION™ is the next evolution of IPC.
It applies intermittent pneumatic compression to increase venous blood flow1 — helping prevent deep vein thrombosis and pulmonary embolism in at-risk patients. The Kendall SCD™ 700 SMART COMPRESSION™ Controller delivers compression to the leg, foot, or both. Vascular refill detection (VRD) is unique to the Kendall SCD™ 700 Compression System SMART COMPRESSION™.
In Stock
- Delivery & Return
Delivery
We ship to all address in Canada and all 50 states, Washington DC. All orders are shipped with a Canada Post tracking number. Always free shipping for orders over $500. During sale periods and promotions the delivery time may be longer than normal. Items marked "On-Demand" "Special Order" "On Backorder" are not refundable or eligible for return as they are ordered on a case by case basis.Return
Due to the nature of the products we sell, and for health safety concerns for our valuable customers, our products are non-returnable (sales are final). This policy will be strictly enforced.Help
Give us a shout if you have any other questions and/or concerns. Email: sales@mecp.ca Phone: +1 (437) 990-9174 - Ask a Question
SMART features of the Kendall SCD™ 700 Controller:
SMART Compression Cycles
- Measure venous refill time using Vascular Refill Detection (VRD) technology and customize compression cycles automatically for each patient
- Move 1.5x more blood per hour
- Adjust accordingly when a patient’s needs change over time
SMART Patient Compliance
- Displays the patient’s true wear time by nursing shift
- Features Patient Sensing™ technology, which alerts the nurse of removed sleeves
- Provides a measurement tool to support true compliance to therapy
More features of the controller:
- Animated alerts — Icons show the cause of an error and how it can be resolved
- Visibility — Graphic user interface featuring large icons on a 3.2-inch color LCD screen
- Durability — Limited liquid ingress (rating of IP23), robust Xylex™ material, and protected battery
- Low noise — Soft overmolding with vibration dampeners for a quiet controller
- Ease of cleaning — Smooth, grooveless surfaces and slim profile; compatible with most hospital-grade cleaning agents
- Tubing assembly is provided for use with the Kendall SCD™ 700 controller.
1 Kakkos SK, Szendro G, Griffin M, Daskalopoulou SS, Nicolaides AN. The efficacy of the new SCD response compression system in the prevention of venous stasis. J Vasc Surg. 2000;32(5):932-940; Fig 5.
Additional Information:
- Brand: Kendall SCD™
Weight | 4 kg |
---|---|
Dimensions | 20 × 30 × 20 cm |
Related Products
Individually checked with maximum precision for perfect workmanship, pattern, and finish.
In Stock
Individually checked with maximum precision for perfect workmanship, pattern, and finish.
- Material: Stainless Steel.
In Stock
- Diarrhea
- Nausea
- Vomiting
- Headache
In Stock
SPECULUM VAGINAL GRAVES MED 1EA
In Stock
- Autoclavabl
Disposable / Reusable: Disposable
Colour: Blue
Length: 5″
e.FORCEPS PLASTIC DISP 5IN BLUE AUTOCLAVABLE 50EA/PK 30PK/CA
In Stock
ProActive Self Adhesive Electrode is a versatile and reusable electrode that can be used with most TENS and muscle electro stimulators. With a built-in conductive gel surface that remains effective for up to 30 uses,ProActive Self Adhesive Electrode is pre-wired and pre-gelled for easy and convenient application. The flexible cloth backing allows the electrode to conform to all body surfaces, while the rounded edges prevent electrode curl-up. The hypo-allergenic gel keeps the skin soft and the anchored pigtail prevents wire pull-out, increasing the usage life. Available in a variety of shapes and sizes, these latex-free electrodes are perfect for multiple treatment zones.
Self-adhesive, pre-gelled & reusable Electrodes for use with most TENS and muscle electro stimulators
- Built-in conductive gel surface remains effective for up to 30 uses
- Flexible cloth backing allows the electrode to easily and durably conform to all body surfaces
- Pre-wired and pre-gelled for easy and convenient application
- Long lasting, hypo-allergenic gel keeps skin soft
- Rounded edges for prevention of electrode curl-up
- Anchored pigtail prevents wire pull-out and increases usage life
- Available in a variety of shapes and sizes for application to multiple treatment zones
- Latex-Free
In Stock
Semaglutide API Product Description:
COA Available Product with NDC Code
Available in the US and Canada.
Semaglutide API is indicated for improving glycemic control in adults with type 2 diabetes mellitus, in conjunction with diet and exercise. The approved therapeutic doses are 0.5 mg and 1 mg. Type 2 diabetes is a chronic metabolic disorder characterized by high blood sugar, insulin resistance, and insufficient insulin production. The onset of this condition is linked to the inability of beta cells to respond to increased plasma glucose, predominantly caused by lifestyle factors such as overweight and obesity. The key feature of type 2 diabetes is insulin resistance, which reduces insulin’s effectiveness at normal concentrations. Insulin secretion is stimulated by incretins like glucagon-like peptide 1 (GLP-1), which also delays gastric emptying and induces satiety.
Mode of Action:
Semaglutide API enhances glucose control through various mechanisms, including increased insulin secretion, slower gastric emptying, and reduced postprandial glucagon and food intake. The drug mimics the activity of GLP-1, a key hormone in glucose management, thanks to structural modifications that improve its stability against degradation by enzymes like dipeptidyl peptidase-4 (DPP-4). These modifications also promote specific binding to plasma albumin and prevent incorrect binding of fatty acids, resulting in an extended half-life and improved patient compliance.
Pharmacodynamics:
Clinical trials show that semaglutide significantly reduces glycated hemoglobin (HbA1c) compared to other medications, including sitagliptin, exenatide, and insulin glargine U100. HbA1c is a standard measure of high glucose levels, reflecting long-term blood sugar control. Additionally, semaglutide has been shown to reduce body weight, lower fasting and postprandial glucose levels, and decrease fasting triglycerides and VLDL cholesterol.
Metabolism:
Semaglutide is slowly but extensively metabolized before excretion, with 83% of the administered dose found unchanged in plasma. Six different metabolites have been identified, with the major metabolite accounting for 7.7% of the dose. The drug is primarily degraded by enzymes such as DPP-4 and neural endopeptidase (NEP), which inactivate semaglutide and hydrolyze its peptide bonds.
Toxicity:
In preclinical studies, mild c-cell hyperplasia and other effects, including liver necrosis and centrilobular hypertrophy, were observed at doses significantly higher than those used clinically. High doses also resulted in ECG abnormalities and tissue vacuolation.
IUPAC:
17-{[(1R)-3-[(2-{2-[({2-[2-({[(5S)-5-[(2S)-2-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-{2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-2-methylpropanamido}-4-carboxybutanamido]acetamido}-3-hydroxybutanamido]-3-phenylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carboxypropanamido]-3-methylbutanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-4-carboxybutanamido]acetamido}-4-carbamoylbutanamido]propanamido]propanamido]-5-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-4-carbamimidamido-1-[({[(1S)-4-carbamimidamido-1-[(carboxymethyl)carbamoyl]butyl]carbamoyl}methyl)carbamoyl]butyl]carbamoyl}-2-methylpropyl]carbamoyl}-3-methylbutyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}ethyl]carbamoyl}-2-methylbutyl]carbamoyl}-2-phenylethyl]carbamoyl}-3-carboxypropyl]carbamoyl}pentyl]carbamoyl}methoxy)ethoxy]ethyl}carbamoyl)methoxy]ethoxy}ethyl)carbamoyl]-1-carboxypropyl]carbamoyl}heptadecanoic acid
DrugBank:
DB13928
Formula:
C187-H291-N45-O59
Molecular Mass:
Average: 4113.641
Monoisotopic: 4111.11537713
Synonyms:
Semaglutide / Semaglutide API
SMILES:
CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O
InChi:
InChI=1S/C187H291N45O59/c1-18-105(10)154(180(282)208-108(13)159(261)216-133(86-114-89-200-119-50-40-39-49-117(114)119)170(272)218-129(82-102(4)5)171(273)228-152(103(6)7)178(280)215-121(53-44-72-199-186(192)193)162(264)201-91-141(242)209-120(52-43-71-198-185(190)191)161(263)204-94-151(257)258)230-172(274)131(83-111-45-33-31-34-46-111)219-167(269)126(64-69-149(253)254)214-166(268)122(51-41-42-70-195-144(245)98-290-79-78-289-76-74-197-145(246)99-291-80-77-288-75-73-196-139(240)66-61-127(183(285)286)211-140(241)54-37-29-27-25-23-21-19-20-22-24-26-28-30-38-55-146(247)248)212-158(260)107(12)206-157(259)106(11)207-165(267)125(60-65-138(189)239)210-142(243)92-202-163(265)123(62-67-147(249)250)213-168(270)128(81-101(2)3)217-169(271)130(85-113-56-58-116(238)59-57-113)220-175(277)135(95-233)223-177(279)137(97-235)224-179(281)153(104(8)9)229-174(276)134(88-150(255)256)221-176(278)136(96-234)225-182(284)156(110(15)237)231-173(275)132(84-112-47-35-32-36-48-112)222-181(283)155(109(14)236)227-143(244)93-203-164(266)124(63-68-148(251)252)226-184(287)187(16,17)232-160(262)118(188)87-115-90-194-100-205-115/h31-36,39-40,45-50,56-59,89-90,100-110,118,120-137,152-156,200,233-238H,18-30,37-38,41-44,51-55,60-88,91-99,188H2,1-17H3,(H2,189,239)(H,194,205)(H,195,245)(H,196,240)(H,197,246)(H,201,264)(H,202,265)(H,203,266)(H,204,263)(H,206,259)(H,207,267)(H,208,282)(H,209,242)(H,210,243)(H,211,241)(H,212,260)(H,213,270)(H,214,268)(H,215,280)(H,216,261)(H,217,271)(H,218,272)(H,219,269)(H,220,277)(H,221,278)(H,222,283)(H,223,279)(H,224,281)(H,225,284)(H,226,287)(H,227,244)(H,228,273)(H,229,276)(H,230,274)(H,231,275)(H,232,262)(H,247,248)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,285,286)(H4,190,191,198)(H4,192,193,199)/t105-,106-,107-,108-,109+,110+,118-,120-,121-,122-,123-,124-,125-,126-,127+,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,152-,153-,154-,155-,156-/m0/s1
Purchase of this product is restricted to licensed companies and labs.
In Stock
SYRINGE EAR METAL 4OZ W/2 TIPS 1EA
Feature / Property: Two Tips
In Stock
Feature / Property
This product can be sterilized
Invoice Description
FORCEPS MOSQUITO HALSTEAD STR FRCP HALSTEAD MOSQ STR 12.7CM
In Stock
GRADUATED MEASURE 2000CC 1EA
Individually checked with maximum precision for perfect workmanship, pattern, and finish.
- Material: Stainless Steel.
In Stock
Relieves pain without drugs.
- Give a choice of 3 stimulation modes (Burst, normal, and modulated waveform setting), a choice of 3 different timer settings (15 minutes, 30 minutes, and continuous), and comes complete with all accessories.
- Easy to use Dial controls.
- Protective front cover to keep your TENS unit safe.
- Durable plastic carry case.
- 2 lead wires with built-in guard.
- 4 easy-to-apply reusable comfort gel electrodes.
- 9V Battery.
-
Brand: ProActive™ Pulse™
Feature / Property: Relieves Pain without Drugs, Burst/Normal and Modulated Waveform Setting, 15 Minutes/30 Minutes and Continuous Timer Settings
In Stock